Yarrowia lipolytica is ubiquitous in the environment, opportunistic, and might be considered as one of the causative agents of catheter-related candidemia. Our work aimed to study some virulence factors of Y. lipolytica such as hydrolases production and biofilm formation with comparison to the most frequent Candida specie in human disease. In sum, 58 clinical isolates of Y. lipolytica, 16 C. glabrata, and 12 C. albicans were collected from Intensive care unit (ICU). All were tested for enzymatic production and biofilm formation. All tested isolates of C. albicans and C. glabrata were able to degrade casein, and 98.2% of Y. lipolytica showed caseinase activity but no gelatinase activity was detected in all isolates. Y. lipolytica strains showed significantly lower (3.4%) in vitro phospholipase activity than C. albicans and C. glabrata (P < .05). No significant differences of the hemolytic activity were detected between the three species (P > .05). Concerning biofilm formation, and unlike the results obtained on polystyrene plate, the number of adhered and biofilm cultivable cells obtained by Y. lipolytica after 168 hours of catheter subcutaneous implantation is significantly greater and tends to be more compact and structured hyphal layer. Although C. albicans remains the most pathogenic yeast, development of selective ability of Y. lipolytica to adhere, to form a biofilm on catheter medical devices, and to produce phospholipase and hemolytic enzyme is of particular interest, and it is strongly recommended to be vigilant in the use of medical implanted medical devices, particularly in ICU.
Introduction
Yarrowia lipolytica known as Candida lipolytica is a ubiquitous and opportunistic yeast. But it is rarely responsible for pathogenic infections in humans, which can be due to its low virulence and/or prevalence in the environment or to its status of a commensal in humans.
1-2 Candidemia due to Y. lipolytica is more common in immunocompromised patients during hospitalization and is often a systemic infection related to the use of intravenous catheter. 3 Indwelling catheter devices, especially central venous catheters, were strongly correlated in almost all cases of Y. lipolytica fungemia. These catheters could introduce the yeast pathogen into the blood stream easily. Therefore, Y. lipolytica might be considered one of the causative agents of catheter-related fungemia.
Particular impact was reported at University Hospital (UH) Habib Bourguiba Sfax especially in intensive care unit center (ICU) during the period from October 2012 to June 2014. No isolation of this species was previously reported at the UH Habib Bourguiba Sfax. 4 An epidemiological investigation was undertaken in ICU to look for the origin of the release. A complementary study on Y. lipolytica virulence factors might explain its prevalence. The best known virulence factors in Candida species are linked to the production of phospholipases, proteases, hemolysin, and biofilm production responsible for adherence and invasion.
Our work aimed to study some virulence factors of Y. lipolytica such as hydrolases production and in vitro biofilm formation with comparison to the most frequent Candida specie in human disease, C. albicans and C. glabrata. We also developed catheter related infection in subcutaneous model to evaluate the kinetics of biofilm formation in a rat and to assess the clinical implications.
Materials and methods

Patients and isolates
In sum, 58 strains of Y. lipolytica were isolated essentially in fungemia cases that occurred between October 2012 and June 2014 in the ICU of the UH Habib Bourguiba Sfax (Tunisia). Additionally, 24 clinical blood culture of C. albicans (n = 10) and C. glabrata (n = 14) collected in the same period and four reference strains, C. albicans 3153A, C. albicans ATCC2001, C. glabrata CBS138, and C. glabrata ATCC90020 were included. All the blood specimens from the patients were inoculated into Bactec PED bottles (Becton-Dickinson, USA), which were incubated in the Bactec R 9050 automated culturing system (BD diagnostic Systems 9050, Oxford, UK) at 37
• C for 15 days or until the bottles were positive by the colorimetric detection of CO2. Yeasts grown on SDA plates at 25
• C for Y. lipolytica and at 37
• C for others species were identified according to their morphological characteristics and biochemical profiles. Biochemical tests were performed by using ID 32C (BioMerieux, France). Identification of isolates was confirmed by DNA sequence analysis of the intergenic spacer (ITS) region (primers, ITS-1, 5 -TCCGTAGGTGAACCTGCGG-3 and ITS-4, 5 -TCCTCCGCTTATTGATATGC-3 ). 5 For antifungal drug susceptibility testing, a microtiter broth dilution method based on the Clinical and Laboratory Standards Institute M27-A2 standard (the sensititer yeast one; TREK Diagnostic Systems, East Grimstead, UK) was performed. 6 The minimal inhibitrice concentration (MIC) was determined after 48 h at 35
• C as the lowest concentration of drug that caused significant (90%) growth inhibition.
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Hydrolytic enzyme secretion
Phospholipase production
Phospholipase activity of Candida species were detected by egg yolk agar plate method 9 . The egg yolk medium consisted of 13.0 g SDA, 11.7 g NaCl, 0.11 g CaCl2, and 10% sterile egg yolk. A loopful of an overnight yeast culture (approximately 10 6 cells/ml determined through densitometer was aseptically inoculated onto the medium and incubated at 25
• C for C. albicans and C. glabrata for 5 days. The diameter of the precipitation zone (a) and the diameter of the precipitation zone plus the diameter of the colony (b) were measured. Phospholipase index was designated as Pz = a/b, as described by Price et al. 9 According to this definition, low Pz values mean high enzymatic production and, inversely, high Pz values indicate low enzymatic production. The enzymatic activity was scored into four categories, Quantification of total biomass by crystal violet (CV) staining, after washing, biofilms were fixed with 200 μl of methanol, which was removed after 15 min of contact. The microtiter plates were dried at room temperature, and 200 μl of CV (1% v/v) added to each well and incubated for 5 min. The wells were then gently washed with ultra-pure water. The absorbance of the obtained solutions was read in three separate experiments in a microtiter plate reader (Bio-Tek Synergy HT, Izasa, Lisbon, Portugal) at 570 nm.
In vivo biofilm development on rat subcutaneous model
Yeast cells grown in appropriate temperature, washed and resuspended in phosphate-buffered saline (PBS). A suspension of 1.10 7 cells/ml was prepared in YPG medium.
Polyurethane triple-lumen intravenous catheters (2.4 mm diameter) cut into segments and were incubated overnight in bovine serum at 37
• C. Serum-coated catheters were incubated for 90 min at 25
• C in 1 ml cell suspension. After incubation, catheters were washed twice with PBS before being implanted under the skin of rats as described previously by Ricicova et al. 12 Anesthesia was performed by intravenous injection of ketamine (Panpharma, France) performed 30 min before surgical procedure. Rats were kept asleep during the implantation procedure by a gaseous mix of enflurane (20%) (Alyrane, Pharmacia) and oxygen (80%). The lower back of the rat was shaved and disinfected with 0.5% chlorhexidine in 70% alcohol. A 10 mm incision was made longitudinally and the subcutis was carefully dissected to create three subcutaneous tunnels. 13 Up to six catheter fragments were implanted. The incision was closed with surgical staples, and disinfected with 0.5% chlorhexidine in 70% alcohol. For catheter explantation, rats were euthanized by CO2 inhalation. The skin was disinfected, and catheter fragments were removed from under the subcutaneous tissue and washed twice with PBS.
Biofilm cultivable cell determination
The number of cultivable cells in biofilms was determined by the enumeration of colony-forming units (CFUs) at 1.5, 5, 24, 48, 72, 96, 144, and 168 hours after implantation. For that, explanted catheters were vortexed for 5 min in PBS. Original samples and a 1:10 dilution were plated on dextrose agar in duplicate. CFUs were counted after 2 days at 25
• C for C. albicans and C. glabrata. They are represented as mean of the counts of both dilutions per substrate.
Fluorescence microscopy
Catheters (longitudinally cut) were incubated in PBS with 30 μl of euroimmun conjugate IgAGM (Sigma, France) for 15 min and observed with a Zeiss Axiocam HRm camera using axiovision 3.0 software.
Statistical analysis and reproducibility of results
Statistical analyses were performed using Student's t-test (SPSS version 13.0). Differences were considered significant at P ≤ .05. All in vitro and in vivo experiments were performed respectively at least three times and always using two animals per group.
Results
From (Table 1) . Isolates were collected from 11 women and 44 men, with a mean age of 43 years. The most common risk factors associated with infection were the use of broad spectrum antibiotics (100%), the use of central intravenous catheters and parenteral nutrition (96%), and the long stay in ICU (91%).
In our study, we evaluated the in vitro capacities of 58 Y. lipolytica isolates, 16 C. glabrata and 12 C. albicans isolates to produce phospholipase, hemolysin, and proteases (caseinase and gelatinase enzyme) ( Figure 1 ). All tested isolates of C. albicans and C. glabrata were able to degrade casein, but no gelatinase activity was detected for all isolates. The average caseinase production in these two species is respectively (0.58 ± 0.09) and (0.61 ± 0.05). In sum, 57 among 58 strains (98.2%) of Y. lipolytica showed positive caseinase activity. Among them, 55 strains (94.8%) showed a strong caseinase activity with an average production of (0.60 ± 0.09) ( Table 2) .
Hemolysin activity was observed in 11 C. albicans strains (91.6%) and 14 C. glabrata strains (87.5%). The average hemolysin production were (0.58 ± 0.2) and (0.61 ± 0.25), respectively. And 51 isolates of Y. lipolytica (87.9%) had a hemolysin activity and exhibited an average production of (0.60 ± 0.28) ( Table 2) . No significant differences in the hemolytic activity were detected between the three species (P > .05).
Most of C. albicans isolates (83.3%) showed a positive phospholipase activity (Table 2) ; 68.7% of C. glabrata strains (11 isolates) demonstrated positive activity and 37.5% (6 isolates) had a strong activity. However, 96.6% of Y. lipolytica strains showed no capacity in vitro to degrade phospholipids, and this activity was significantly lower than C. albicans and C. glabrata (P < .05).
Correlation analysis results revealed that all virulence factors analyzed were independent and do not influence each other. Moreover, a negative correlation (P ≤ .05) between hemolysin and phospholipase production was detected.
Quantification results of the biofilm formation in vitro are shown in Figure 2 . The amount of biofilm formed in each case was estimated in triplicate and an average was calculated for each isolate. The amounts of obtained biofilms were (Abs moy, 0.379 ± 0.18) for C. albicans isolates, (Abs moy, 0.245 ± 0.07) for C. glabrata isolates and (Abs moy, 0.256 ± 0.05) for Y. lipolytica isolates. For each strain, a small change in Abs (570nm) value was noted. It was noted that the total amount of biomass formed in vitro by C. albicans isolates was slightly higher than that for C. glabrata (P < .05) and Y. lipolytica (P < .05). The highest level of absorbance was observed for one reference strain, C. albicans 3153A (0.91 ± 0.26). The latter produced a 3.7 times and 3.5 times the amount of biofilm produced by C. glabrata and Y. lipolytica strains, respectively.
To gain insights into the kinetics of biofilm growth and cell morphology within biofilm in the subcutaneous model, CFU and fluorescence microscopy images were collected. Three isolates were selected as they were high biofilm formers in polystyrene plate C. albicans 3153A, Y. lipolytica BC507 and C. glabrata BC94. In vivo biofilms were collected from six devices from two independents biological experiments at eight time points (1.5h, 5h, 24h, 48h, 72h, 96h, 144h, and 168h). Images of fluorescence microscopy were captured after 48h and 168h. Mature biofilms were observed after 2 days as shown by the presence of mainly hyphal cells. The data from Y. lipolytica biofilms were compared to those developed by C. albicans and C. glabrata as shown in Figure 3 . In contrast to C. albicans and C. glabrata, biofilms of Y. lipolytica tend to be more compact and structured hyphal layer. After adhesion phase of 90 min a few hundreds of cells were attached to the devices. Catheters that were infected with 1. higher than C. albicans and C. glabrata biofilm (P ≤ .05) (Figure 4 ). We also observed Candida cell dissemination into the tissue surrounding the catheters. However, we never recovered C. albicans or C. glabrata cells from other organs including kidney, liver, lungs, and blood of animals with catheter infections. But Y. lipolytica was recovered from blood 6 days after implantation.
Discussion
Nosocomial infections by non-Candida albicans (NCAC) species have emerged as an increasing problem during the last two decades. [14] [15] Moreover, Y. lipolytica appears to display higher potential to cause catheter-related fungemia and possesses several virulence factors that can enhance the progression of infections than C. albicans and other NCAC species.
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Hydrolytic enzymes also play an important role in the pathogenicity of candidiasis. [16] [17] These enzymes facilitate tissue invasion and helps the pathogen to adapt to its host by improving their condition of survival. Most studies investigated hydrolase activity among the most common species such as C. albicans, C. tropicalis, and C. parapsilosis. However, Y. lipolytica was considered to be of low pathogenic grade and only few studies investigated its virulence mechanisms.
We studied the production of several hydrolases, among them phospholipases which are enzymes involved in the pathogenicity of C. albicans strains. 18 Our results confirmed the role of phospholipases in the virulence of C. albicans, where 83.3% of strains were able to produce a large amount of phospholipase. However, 68.75% of C. glabrata strains and only 3.4% of Y. lipolytica strains from vaginal site showed phospholipase activity. Similarly, Kantarcioglu et Yücel studied the production of phospholipase in 4 C. lipolytica and 31 non-albicans strains and found that only a few strains of C. glabrata and C. kefyr were able to produce phospholipase and that blood isolates generally produce much higher levels than noninvasive isolates. 19 Unlike these authors, our Y. lipolytica phospholipase producer was isolated from vaginal site. Oksuz et al. found in a similar study that 53% of C. albicans strains produced a relatively large amount of phospholipase, but only 14% of non-albicans strains were producers. 20 Hemolysin is an enzyme that degrades the erythrocytes of the host, thereby releasing the iron for later use during invasive infections. In our study, all isolates have similar capabilities to produce hemolysin, and unlike phospholipase that has been mainly secreted by C. albicans, hemolysin appears to be an important virulence factor for the three studied species. Rossoni et al. tested the hemolysin activity of 50 strains of Candida spp. and found that all strains of C. albicans and 92% of C. glabrata isolates showed hemolytic activity but the level of hemolysin production was significantly higher in C. glabrata isolates. 17 In our study, extracellular secretion of proteases was studied as caseinase and gelatinase. Proteinases are capable of degrading host epithelial and mucosal barrier proteins such as collagen, keratin, and mucin. They also help Candida to resist cellular and humoral immunity by degrading antibodies, complement, and cytokines. 21 None of the isolates showed gelatinase activity. On the contrary, caseinase activity was similarly detected in most isolates of three species. Ramesh et al. also tested the caseinase and gelatinase activity in 50 strains of Candida spp. and demonstrated that all isolates are able to degrade casein but any isolate was capable of hydrolyzing the gelatin and have concluded that caseinase is an enzyme that strongly contributes to the virulence of Candida yeasts. 10 We conclude that C. albicans showed the highest hydrolytic capacity (a fairly significant production of proteases and phospholipases), followed by C. glabrata, which was less productive in phospholipase. Another important virulence factor was investigated, the biofilm formation, which is always considered as protective barrier against antifungal treatment and an excellent mechanism to escape the host defense system. Many authors claimed that biofilm formation is highly dependent on growth condition. [22] [23] Branchini et al. assumed that the ability of the organism to adhere to plastic catheter and to cause infections was significantly associated with the use of parenteral nutrition where the glucose level in the administrated solution is usually high. In our study, 96% of patients had parenteral nutrition. 24 To study biofilm formation in vitro, we used polystyrene plates for growth of biofilm for several reasons. This material is widely used for diagnosis of a variety of microorganism and showed excellent adhesion capacity in addition to their availability in most laboratories. [25] [26] In our study, all strains showed in vitro ability to adhere to the polystyrene surface and to form a biofilm, but the biofilm amount produced by Y. lipolytica was significantly lower than that produced by C. albicans and C. glabrata (P < .05). Similarly, Fahmi et al. showed that C. albicans remains the fungal species most often associated with biofilm formation and C. glabrata showed lowest filamentation power and deduced that this phenomenon does not only depend on the species but also on the tested isolates.
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Mature biofilms formation and subsequent production of extracellular matrix strongly depend not only on the species but also on the substrate or indwelling devices. [22] [23] In our setting, to compare the ability of C. albicans, C. glabrata and Y. lipolytica to produce biofilm, we used a second substrate (intravenous catheter fragments) that usually was considered as a potential niche for the accession and formation of biofilm in Candida spp. For biofilm growth kinetics in each species, a single strain per species was used for all rats at the same fungal concentration, biofilm formation in this case only depend on the species and the substrate. In the first hours following the introduction of a catheter in vivo, the number of cells decreased for all three species. Several hypotheses may explain this. During this period, the cells can be more easily detached because of their encounter with the host resulting in a decrease in biomass. Additionally, the presence of antigen and yeast cell debris will promote the production of antibodies and subsequently eliminate a significant number of yeasts. 13 The gradual increase in the amount of biofilm produced from 24-hour incubation describes the different phases of maturity of the biofilm which has reached a steady level after 168 h (7th day after implantation). By comparing the amount of biofilm obtained after 168 hours for the three species studied, we noticed that unlike the results obtained on polystyrene plate, the number of adhered and biofilm cultivable cells obtained by Y. lipolytica is significantly greater than that obtained by C. albicans and C. glabrata although Y. lipolytica and C. glabrata have a similar growth rate (≈13 cells/μl). For all tested isolates, a clear relation between adhesion and biofilm formation was observed and in vivo Candida biofilm development strongly depended on the number of cells attached per device. In the same context, Silva et al. showed that C. glabrata adhered to silicone, in the presence of urine, at higher levels than did either C. tropicalis or C. parapsilosis. Additionally, C. glabrata has also been reported to have a two-fold greater tendency to adhere to dentureacrylic surfaces compared with C. albicans. 25 Negri et al. affirmed that adhesion ability to biotic and abiotic surface depends not only on the species but also on the strain type. 28 No one recovered C. albicans and C. glabrata fungemia from kidneys, nor from blood of the implanted rats suggesting the recognition and/or killing of the foreign organism by the immune system without detectable dissemination, even in the dexamethasone-treated animals. 13, 29 In our setting, a charge of 1282 Y. lipolytica cells/μl per catheter fragment Thirty six devices were collected from two independent biological experiments at each time point. Adhesion stade and mature biofilm formation were marked in histogram.
was able to disseminate in blood 6 days after implantation. The consistent slime production previously described by D'Antonio et al. responsible for its capacity to adhere and to colonize the central catheter with the immune status of the host both have led to this invasion. 2 We conclude that even though C. albicans remains the most pathogenic yeast, development of selective ability of Y. lipolytica to adhere and form a biofilm on catheter medical devices and to produce some hydrolytic enzymes such as phospholipase and hemolytic ones, is of particular interest as it has sometimes low susceptibility to some antifungal agents. Despite that it is not possible to establish a relation among the analyzed virulence factors, it is interesting to note that some strains seem to be more virulent than others and it is strongly recommended to be vigilant in the use of medical implants, particularly in intensive care units.
